A validated chiral chromatographic method for the enantiomeric separation of acalabrutinib

Author:

Rayala V. V. S. Prasanna Kumari1ORCID,Trivedi Kashyap Ajaybhai1,Upadhyayula Suryanarayana Murthy1,Gunnam Srinivasu2ORCID,Borkar Roshan M.1ORCID,P Radhakrishnanand1ORCID

Affiliation:

1. Department of Pharmaceutical Analysis National Institute of Pharmaceutical Education and Research (NIPER)‐Guwahati Guwahati India

2. Daicel Chiral Technologies‐India (P) Limited Hyderabad India

Publisher

Wiley

Subject

Organic Chemistry,Spectroscopy,Drug Discovery,Pharmacology,Catalysis,Analytical Chemistry

Reference16 articles.

1. The ever‐increasing importance of cancer as a leading cause of premature death worldwide

2. Global health estimates: leading causes of death n.d.https://www.who.int/data/maternal-newborn-child-adolescent-ageing/advisory-groups/gama/gama-advisory-group-members(accessed November 21 2021).

3. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

4. AstraZeneca Acerta Pharma Acalabrutinib granted breakthrough therapy designation by US FDA for the treatment of patients with mantle cell lymphoma.2017.https://www.astrazeneca.com/media-centre/press-releases/2017/acalabrutinib-granted-breakthrough-therapy-designation-by-us-fda-for-the-treatment-of-patients-with-mantle-cell-lymphoma-01082017.html(accessed November 21 2021).

5. U.S. Food and Drug Administration.FDA approves new treatment for adults with mantle cell lymphoma FDA.2020.https://www.fda.gov/news‐events/press‐announcements/fda‐approves‐new‐treatment‐adults‐mantle‐cell‐lymphoma(accessed November 21 2021).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3